X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs SUN PHARMA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD SUN PHARMA BIOCON LTD/
SUN PHARMA
 
P/E (TTM) x 72.2 26.3 274.7% View Chart
P/BV x 6.8 3.8 177.0% View Chart
Dividend Yield % 0.2 0.6 30.5%  

Financials

 BIOCON LTD   SUN PHARMA
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
SUN PHARMA
Mar-17
BIOCON LTD/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,162842 138.0%   
Low Rs483572 84.3%   
Sales per share (Unadj.) Rs194.6131.6 147.8%  
Earnings per share (Unadj.) Rs34.432.7 105.2%  
Cash flow per share (Unadj.) Rs48.338.0 127.1%  
Dividends per share (Unadj.) Rs1.003.50 28.6%  
Dividend yield (eoy) %0.10.5 24.6%  
Book value per share (Unadj.) Rs241.9152.7 158.4%  
Shares outstanding (eoy) m200.002,399.26 8.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.25.4 78.6%   
Avg P/E ratio x23.921.6 110.5%  
P/CF ratio (eoy) x17.018.6 91.5%  
Price / Book Value ratio x3.44.6 73.4%  
Dividend payout %2.910.7 27.2%   
Avg Mkt Cap Rs m164,4401,696,877 9.7%   
No. of employees `0009.217.5 52.7%   
Total wages/salary Rs m7,47049,023 15.2%   
Avg. sales/employee Rs Th4,213.918,028.3 23.4%   
Avg. wages/employee Rs Th809.02,798.8 28.9%   
Avg. net profit/employee Rs Th745.24,479.5 16.6%   
INCOME DATA
Net Sales Rs m38,911315,784 12.3%  
Other income Rs m1,5716,232 25.2%   
Total revenues Rs m40,482322,016 12.6%   
Gross profit Rs m9,795100,893 9.7%  
Depreciation Rs m2,77212,648 21.9%   
Interest Rs m2603,998 6.5%   
Profit before tax Rs m8,33490,479 9.2%   
Minority Interest Rs m1630-   
Prior Period Items Rs m099 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,61612,116 13.3%   
Profit after tax Rs m6,88178,462 8.8%  
Gross profit margin %25.231.9 78.8%  
Effective tax rate %19.413.4 144.8%   
Net profit margin %17.724.8 71.2%  
BALANCE SHEET DATA
Current assets Rs m40,477329,537 12.3%   
Current liabilities Rs m16,783178,870 9.4%   
Net working cap to sales %60.947.7 127.6%  
Current ratio x2.41.8 130.9%  
Inventory Days Days6079 75.5%  
Debtors Days Days8383 99.5%  
Net fixed assets Rs m45,073204,766 22.0%   
Share capital Rs m1,0002,399 41.7%   
"Free" reserves Rs m47,377363,997 13.0%   
Net worth Rs m48,377366,397 13.2%   
Long term debt Rs m21,08214,361 146.8%   
Total assets Rs m93,942614,102 15.3%  
Interest coverage x33.123.6 139.9%   
Debt to equity ratio x0.40 1,111.8%  
Sales to assets ratio x0.40.5 80.5%   
Return on assets %7.613.4 56.6%  
Return on equity %14.221.4 66.4%  
Return on capital %12.624.8 50.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,98844,118 29.4%   
Fx outflow Rs m7,89924,484 32.3%   
Net fx Rs m5,08919,634 25.9%   
CASH FLOW
From Operations Rs m6,40070,822 9.0%  
From Investments Rs m-4,985-42,216 11.8%  
From Financial Activity Rs m-1,775-22,854 7.8%  
Net Cashflow Rs m-4736,107 -7.7%  

Share Holding

Indian Promoters % 40.4 63.7 63.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 5.1 163.7%  
FIIs % 10.7 23.0 46.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 8.3 239.8%  
Shareholders   109,995 133,026 82.7%  
Pledged promoter(s) holding % 0.0 0.5 7.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   VENUS REMEDIES  MERCK LTD  NOVARTIS  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare BIOCON LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex & Nifty Open at Record Highs; Banking & PSU Stocks Rally(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.46% while the Hang Seng is up 0.28%. The Shanghai Composite is trading up by 0.43%.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Jan 18, 2018 09:57 AM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS